Stockreport

Annovis to Host Year-End Investor Webcast on December 11, 2024

Annovis Bio, Inc.  (ANVS) 
PDF MALVERN, Pa., Nov. 25, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurode [Read more]